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WILLIAM A. LAFIELD
Radiosensitivity is a term used to designate the reaction of cells
to radiation, and the radiotherapy of malignant disease is based upon
the difference in radiosensitivity between neoplastic cells and the nor-
mal cells which surround them.
The factors that enter into radiosensitivity are many. The gen-
eral condition of the patient often has a most important influence on
the behavior of the tumor under treatment, and the metabolic
activities of tumor cells are likewise important in determining sen-
sitivity. There is a definite relationship between the grade of malig-
nancy of a tumor and its reaction to radiation, since the latter is in
direct ratio to the rapidity of its growth. Indeed, the law of Ber-
gonie and Tribondeau states that tumors composed of rapidly
multiplying cells, especially those of the embryonal type, are highly
susceptible to radiation.
From the practical point of view, radiologists consider the em-
bryonal type of tumor especially favorable to radiation; adenoma
and adenocarcinoma have a tendency to produce glandular structures
which render them more resistant; epidermoid carcinoma, arising
from squamous cells, is markedly radiosensitive; and osteogenic and
neurogenic sarcomas are the most resistant of neoplasms.
The location of a tumor is often an important factor in its re-
action. Tumors growing in bone are many times invulnerable to
repeated radiation, and mammary tumors, because of their growth
in the fatty tissues of the breast and axilla, are extremely difficult
to treat.
In addition to these factors resident within the tumor itself or
based upon its location, many other conditions contribute to the
sensitivity or resistance of the tumors to radiation. Among these
may be mentioned active infection, which interferes with successful
radiation; indeed, the inflammatory process may be aggravated, and
in many instances the growth of the tumor cells is accelerated . In
cancer of the mouth, microbial infection unfavorably influences ef-
forts to control maligniancy.YALE JOURNAL OF BIOLOGY AND MEDICINE
The general condition of the patient also exerts an effect upon
the results of radiation, and it has been suggested that possibly the
activity of the endocrine glands may play some role in the tissue re-
action. Tumors, in patients with anemia and cachexia, may fail
to respond to an intensive radiation which, in patients with good gen-
eral health is effective.
Clinical experience and experimental evidence have demonstrated
the fact that neoplastic cells may develop an acquired resistance to
radiation following successive inadequate dosage, and this should be
very seriously considered by those assuming the responsibility for
radiation therapy. We all too frequently encounter indolent tumors
that, following a long succession of treatments by radium or X-ray,
have become so resistant to radiation that they fail to respond favor-
ably, even to very high dosage. The explanation of this phenomenon
is difficult, but the fact remains that repeated insufficient treatments
by radiation diminish the radiosensitiveness of human cancer.
To cure some neoplasms it is necessary to give a radiation dose
that is sufficient to destroy epidermis; for example, in radium treat-
ment of malignancies of the skin, the mouth, and the vagina, there
is a fair margin of safety with what we may determine to be the steri-
lizing dose. If a severe reaction, comparable perhaps to a second de-
gree burn, is produced in the marginal zone of supporting epidermis,
it is unimportant, since it heals quickly. On the other hand, the death
of connective tissue stroma resulting from radium necrosis, presents
a serious complication.
The varying radiosensitivity of neoplasms precludes the formu-
lation of a definite cancer dose of radiant energy. Skin erythema
lacks the precision necessary for establishing a standard unit. It
has been accepted generally, in accord with Regaud's suggestion, that
a dose sufficient to cause a suppression of spermatogenesis in the
testes, which is analogous to the dose required to cause shedding of
the epidermis, be considered a standard unit. This phenomenon, as
he observes, is more evident and more clearly defined than is the
erythema of the skin resulting from radiation, and the limits of the
dose that will produce it vary less than do those of the dose that will
cause an erythema. The dose necessary to sterilize a certain neoplasm
is given as a percentage of the epidermicidal dose.
In considering this subject, it is essential to remember that the
growth of cancer depends upon an indefinite multiplication of cells;
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that in the beginning, cancer is a localized disease, and in that stage
is amenable to radiation. Outside of the zone of clinically apparent
cancer, there is a latent zone of implantation, discernible only micro-
scopically. Whether we elect to treat the neoplasm surgically or by
radiation, this outer zone must be effectually treated, marginal re-
currences being frequent.
If the malignancy is to be treated by radiation, every part of
the neoplasm must be given a lethal dose. If the limit of radio-
sensibility of the normal surrounding structure is exceeded, a lesion
of the epithelium will occur. It follows, therefore, that extreme
accuracy of dosage and treatment is required of the radiotherapist.
It is useless to subject patients to large doses of radiation when the
tumor is of the type that is highly resistant and, on the other hand,
patients should be spared too heavy radiation if lighter doses will
suffice.